Electromyography (EMG)-triggered transcutaneous spinal cord and hip stimulation for gait rehabilitation in persons with chronic stroke: a randomized, controlled trial.

Researchers in Japan tested a new piece of equipment called FAST walk, which combines electrical stimulation of the spinal cord and hip muscles triggered by the body's own muscle activity during walking, paired with treadmill training for people recovering from stroke. They randomly split 20 people with chronic stroke into three groups: one using FAST walk plus treadmill training, one using spinal stimulation alone plus treadmill training, and one doing treadmill training only. After 10 sessions over five weeks, the FAST walk group showed improvement in walking speed, while the other two groups did not.

However, when the researchers compared all three groups directly, the differences between them were not statistically significant, which means the improvements in the FAST walk group could have occurred by chance. The study suggests FAST walk is safe and may help some people walk faster, but it did not outperform the other approaches in a clear, measurable way.

This study looked at whether a new tool that sends electrical signals to your spinal cord and hip muscles during walking could help people who have had a stroke regain walking speed. Twenty people with stroke participated, and those who used the FAST walk system alongside treadmill practice did show their walking times getting faster over the five weeks of the study.

That said, people who did treadmill training without the electrical stimulation did not improve at the same rate, but the overall differences between the groups were small enough that researchers cannot be confident the special system made the real difference. The good news is that using the equipment was safe and caused no harm.

Right now, the evidence is too uncertain to know whether this approach will become a standard part of stroke rehab, but it is being studied and may be worth learning more about.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This trial examined whether EMG-triggered transcutaneous spinal and hip stimulation adds benefit to treadmill-based gait training in chronic stroke. The FAST walk group showed within-group improvement in 10-metre walking time at post-intervention and four-week follow-up, whereas the spinal stimulation alone and treadmill-only groups did not.

Importantly, the between-group comparison was not statistically significant, so we cannot conclude FAST walk outperformed the alternatives. The small sample size and modest effect sizes suggest this is exploratory evidence rather than definitive.

The mechanism of benefit remains unclear from this abstract; whether the improvement reflects the combined stimulation, the motor practice itself, or simply natural recovery over time cannot be determined. Further work with larger samples and longer follow-up would be needed to establish whether this technology offers a clinically meaningful advantage over conventional approaches.